This page contains a Flash digital edition of a book.
Needle-free systems


References 1. National Audit Office (NAO). A Safer Place to Work: Improving the Management of Health and Safety Risks to staff in NHS.2003. Trusts. http://tinyurl.com/bnd4zc9 (Last accessed: August 30th 2012).


2. Health Protection Agency (HPA), Health Protection Services; Public HealthWales; Public Health Agency Northern Ireland; Health Protection Scotland. Eye of the Needle. United Kingdom Surveillance of Significant Occupational Exposure to Bloodborne Viruses in HealthcareWorkers. London; Health Protection Agency. December 2012.


3. Hung JC, Krause SJ, Schmit CL. Sensible Approaches to Avoid Needle Stick Accidents in Nuclear Medicine J Nucl Med Technol 1999;27:290–3.


4. Wittmann A. In European Biosafety Network: Toolkit for implementation of the European directive on prevention of sharps injuries. (Council Directive 2010/32/EC) in Member States. 2011. Available at; http://www.


europeanbiosafetynetwork.eu/EBN%20Toolkit%20 2011.pdf (Last accessed: August 30th 2012).


5. Health and Safety Executive (HSE). Information Sheet MISC615 Safe handling of cytotoxic drugs. Available at: www.hse.gov.uk/pubns/misc615.pdf. (Last accessed: August 30th 2012).


6. Royal College of Nursing. Wipe It Out: One Chance to get it Right. 2012. RCN, London. http://www.rcn. org.uk/__data/assets/pdf_ file/0008/427832/004166.pdf (Last accessed: August 30th 2012).


7. National Institute for Health and Clinical Excellence (NICE). Infection: prevention and control of healthcare-associated infections in primary and community care. Clinical Guideline 139. 2012. Available at: http://www.nice.org.uk/nicemedia/ live/13684/58656/58656.pdf (Last accessed: August 30th 2012).


8. Department of Health (DH). Immunisation Against Infectious Disease. 2006 The Stationery Office, London.


9. Haiduven DJ, Simpkins SM, Phillips ES, Stevens DA. A survey of percutaneous/mucocutaneous injury reporting in a public teaching hospital. J Hosp Infec 1999;41(2):151–4.


10. Costigliola V, Letondeur C, Strauss K. Needlestick injuries in European nurses in diabetes. Diabetes Metab 2012;38:S10–S14.


11. Department of Health (DH). HIV Post-Exposure Prophylaxis: Guidance from the UK Chief Medical Officers’ Expert Advisory Group on AIDS. 2008. The Stationery Office, London.


12. Centers for Disease Control and Prevention. Workbook for Designing, Implementing, and Evaluating a Sharps Injury Prevention Program. 2008. www.cdc.gov/sharpssafety/pdf/ sharpsworkbook_2008.pdf (Last accessed: August 30th 2012).


13. Training for Development of Innovative Control Technologies. Safety Feature Evaluation Forms. 1998. www.tdict.org/evaluation2.html (Last accessed: August 30th 2012).


14. Adams D, Elliott TS. A comparative user evaluation


of three needle-protective devices. Br J Nurs 2003;12(8);470–4.


15. Health and Safety Executive (HSE). An Evaluation of the Efficacy of Safer Sharps Devices: Systematic Review. 2012. www.hse.gov.uk/research/rrpdf/ rr914.pdf (Last accessed: August 30th 2012).


16. Roff M, Health and Safety Laboratory. Splatter hazard from syringe needle protectors an unintended consequence. Presented at the British Occupational Hygiene Society. April 2011. Available at; http://www.bohs.org/uploadedFiles/ Events/Past_Events/4b%20-%20M%20Roff.pdf . (Last accessed: August 30th 2012).


17. Glenngård AH, Persson U. Costs associated with sharps injuries in the Swedish health care setting and potential cost savings from needle-stick prevention devices with needle and syringe. Scand J Infect Dis 2009;41(4):296–302.


18. Skinner v Scottish Ambulance Service 2004SC 790. Scottish Court Ruling; 8 July 2004. http://www. scotcourts.gov.uk/opinions/A32403.html Last accessed: 17th September 2012.


19. Health and Safety Executive. 2010. http://www. hse.gov.uk/prosecutions/case/case_details. asp?SF=CN&SV=4206786. Last accessed: 17th September 2012.


20. European Agency for Safety and Health at Work. Council Directive 2010/32/EU: implementing the framework agreement on prevention from sharps injuries in the hospital and healthcare sector concluded by HOSPEEM and EPSU. Official Journal of the European Union. 2010 June 01.


23 www.hospitalpharmacyeurope.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28